These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3469997)

  • 1. Short-term in vitro chemosensitivity testing of tumours of the ovary, cervix and uterus. Measurement of DNA metabolism by 3H thymidine incorporation.
    Khoo SK; Hurst T; Webb MJ; Mackay EV
    Aust N Z J Obstet Gynaecol; 1986 Nov; 26(4):288-94. PubMed ID: 3469997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemosensitivity testing of ovarian cancer: results of a rapid in vitro biochemical assay.
    Khoo SK; Hurst T; Webb MJ
    Aust N Z J Obstet Gynaecol; 1985 Aug; 25(3):215-20. PubMed ID: 3866561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin chemotherapy of ovarian cancer: is short-term in vitro chemosensitivity predictive of long-term patient survival?
    Khoo SK; Hurst T; Webb MJ; Dickie G; Kearsley J; Parsons PG; Mackay EV
    Aust N Z J Obstet Gynaecol; 1988 Nov; 28(4):313-7. PubMed ID: 3250450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug sensitivity testing of gynecologic tumors using Volm's test and stem cell assay].
    Eidtmann H; Jonat W; Maass H
    Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):477-81. PubMed ID: 4029587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemosensitivity testing of a novel platinum analog, nedaplatin (254-S), in human gynecological carcinomas: a comparison with cisplatin.
    Koshiyama M; Kinezaki M; Uchida T; Sumitomo M
    Anticancer Res; 2005; 25(6C):4499-502. PubMed ID: 16334133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of in vitro drug sensitivity testing based on short-term effects on DNA and RNA metabolism in ovarian cancer.
    Khoo SK; Hurst T; Webb MJ; Dickie G; Kearsley J; Parsons PG; Mackay EV
    J Surg Oncol; 1989 Jul; 41(3):201-5. PubMed ID: 2747246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of an antimetabolic assay and an antiproliferative assay, both using 3H-thymidine incorporation, to test drug sensitivity of human tumors.
    Zaffaroni N; Silvestrini R; Grignolio E; Villa R; DeMarco C
    Int J Cell Cloning; 1988 Nov; 6(6):392-403. PubMed ID: 2466088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of a human tumour clonogenic cell culture system in gynaecological oncology: review and personal experience.
    Verheijen RH; Herman CJ; Kenemans P
    Eur J Obstet Gynecol Reprod Biol; 1984 Apr; 17(1):43-51. PubMed ID: 6734882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A new in vitro chemosensitivity test. Individualized chemotherapy against ovarian cancer and its clinical effect].
    Takamizawa H; Sekiya S; Iwasawa H; Ishige H; Tokita H; Tanaka N
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2293-7. PubMed ID: 2416274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [-Chemosensitivity testing in gynecologic oncology. Experiences with an ATP bioluminescence assay-].
    Kurbacher CM; Mallmann P; Kurbacher JA; Hübner H; Krebs D
    Geburtshilfe Frauenheilkd; 1996 Feb; 56(2):70-8. PubMed ID: 8647362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Scintillation counting as an in vitro method for assessing the pretherapeutic effectiveness of planned tumor chemotherapy in patients with ovarian cancer].
    Behling H; Krafft W; Wagner F
    Zentralbl Gynakol; 1987; 109(1):42-8. PubMed ID: 3577462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MTS assay as an indicator of chemosensitivity/resistance in malignant gynaecological tumours.
    O'Toole SA; Sheppard BL; McGuinness EP; Gleeson NC; Yoneda M; Bonnar J
    Cancer Detect Prev; 2003; 27(1):47-54. PubMed ID: 12600417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro chemosensitivity test by human tumor colony forming assay].
    Kanamaru H; Hashimura T; Kakehi Y; Kyu LN; Yoshida O
    Hinyokika Kiyo; 1988 Nov; 34(11):1917-21. PubMed ID: 3242365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mullerian inhibiting substance reduction of colony growth of human gynecologic cancers in a stem cell assay.
    Fuller AF; Krane IM; Budzik GP; Donahoe PK
    Gynecol Oncol; 1985 Oct; 22(2):135-48. PubMed ID: 3932140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experiences on in vitro testing of cytostatic sensitivity (oncobiogram) in gynecological tumors].
    Krafft W; Preibsche W; Marzotko F
    Arch Geschwulstforsch; 1973; 41(3):241-7. PubMed ID: 4732846
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro chemotherapy testing of gynecologic tumors: basis for planning therapy?
    Welander CE; Homesley HD; Jobson VW
    Am J Obstet Gynecol; 1983 Sep; 147(2):188-95. PubMed ID: 6614100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soft agarose culture human tumour colony forming assay for drug sensitivity testing: [3H]-thymidine incorporation vs colony counting.
    Jones CA; Tsukamoto T; O'Brien PC; Uhl CB; Alley MC; Lieber MM
    Br J Cancer; 1985 Sep; 52(3):303-10. PubMed ID: 4041359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of the tumor colony assay in therapy planning in malignant ovarian tumors].
    Schieder K; Kölbl H; Bieglmayer C
    Geburtshilfe Frauenheilkd; 1987 Jan; 47(1):41-4. PubMed ID: 3569826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A discussion of the results of chemotherapy on gynecological cancer and the host's immune response.
    Trelford JD
    Proc Natl Cancer Conf; 1970; 6():365-85. PubMed ID: 5458106
    [No Abstract]   [Full Text] [Related]  

  • 20. Systemic therapy for gynecological neoplasms: ovary, cervix and endometrium.
    Pecorelli S; Angioli R; Favalli G; Odicino F
    Cancer Chemother Biol Response Modif; 2003; 21():565-84. PubMed ID: 15338764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.